Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARK JOSEPH WOYSHVILLE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1275612848
CMS profile
798967
Location
MIDDLEBURG HEIGHTS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$30,128.80

104 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARK JOSEPH WOYSHVILLE

NPI 1275612848 · CMS profile ID 798967

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

MIDDLEBURG HEIGHTS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1275612848?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARK JOSEPH WOYSHVILLE, NPI 1275612848, CMS profile ID 798967. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1275612848?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MARK JOSEPH WOYSHVILLE, NPI 1275612848, CMS profile ID 798967. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1275612848?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MARK JOSEPH WOYSHVILLE, NPI 1275612848, CMS profile ID 798967, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1275612848?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

104 matching records · $30,128.80 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 104 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 104.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2,497.5007/02/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1246635158 CMS
Supernus Pharmaceuticals, Inc. $15.8207/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244912226 CMS
E.R. Squibb & Sons, L.L.C. $20.7706/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937301 CMS
Axsome Therapeutics, Inc. $12.6106/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235301963 CMS
Axsome Therapeutics, Inc. $23.4506/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235301966 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $117.5606/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225327639 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.3806/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241428948 CMS
ABBVIE INC. $16.4106/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792093 CMS
E.R. Squibb & Sons, L.L.C. $8.7206/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937303 CMS
Teva Pharmaceuticals USA, Inc. $17.1106/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247462191 CMS
Neurocrine BioSciences, Inc. $14.6906/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243043739 CMS
ABBVIE INC. $22.0205/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792089 CMS
Neurocrine BioSciences, Inc. $14.5005/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243044168 CMS
E.R. Squibb & Sons, L.L.C. $17.8505/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937283 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.1505/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223867270 CMS
ABBVIE INC. $3,375.0005/12/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1204792084 CMS
Axsome Therapeutics, Inc. $9.1205/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235719318 CMS
Axsome Therapeutics, Inc. $21.5205/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235719324 CMS
ABBVIE INC. $33.6504/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792080 CMS
Supernus Pharmaceuticals, Inc. $15.5004/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244912224 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.0904/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241428944 CMS
ABBVIE INC. $15.6004/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792077 CMS
Sage Therapeutics, LLC $25.2904/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211480542 CMS
E.R. Squibb & Sons, L.L.C. $121.6004/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937271 CMS
E.R. Squibb & Sons, L.L.C. $17.3204/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937281 CMS
ABBVIE INC. $3,375.0004/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1204792073 CMS
Vanda Pharmaceuticals Inc. $21.7804/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233015119 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.8204/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241428940 CMS
ABBVIE INC. $13.0004/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792069 CMS
Axsome Therapeutics, Inc. $122.9304/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235792850 CMS
Alkermes, Inc. $21.0603/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222672590 CMS
Janssen Pharmaceuticals, Inc $19.5203/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174780328 CMS
Axsome Therapeutics, Inc. $26.0203/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235463459 CMS
ABBVIE INC. $18.6203/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792065 CMS
ABBVIE INC. $0.0103/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792062 CMS
Alkermes, Inc. $27.1003/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222672588 CMS
Lundbeck LLC $27.6703/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251860863 CMS
ABBVIE INC. $15.1902/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792058 CMS
Vanda Pharmaceuticals Inc. $59.8202/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233015117 CMS
ABBVIE INC. $15.5802/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792053 CMS
Otsuka America Pharmaceutical, Inc. $14.8102/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227542898 CMS
Lundbeck LLC $780.0002/13/2025 Honoraria No dispute reported Delay: No
Change: NEW
06/30/2026 1251860859 CMS
Otsuka America Pharmaceutical, Inc. $23.4802/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227542894 CMS
Neurocrine BioSciences, Inc. $14.7102/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243043685 CMS
Janssen Pharmaceuticals, Inc $19.4202/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174780302 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.6702/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241428936 CMS
Alkermes, Inc. $20.3401/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222672586 CMS
Axsome Therapeutics, Inc. $26.2901/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235390216 CMS
ABBVIE INC. $18.6401/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204792049 CMS
E.R. Squibb & Sons, L.L.C. $21.2101/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184937229 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $715.17 38
PY2020 $6,484.34 32
PY2021 $22,981.60 71
PY2022 $5,178.66 58
PY2023 $48,184.64 122
PY2024 $18,321.56 105
PY2025 $30,128.80 104

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $354,395.59 13
PY2024 Principal investigator $252,639.85 34
PY2023 Recipient $33,596.06 16
PY2023 Principal investigator $659,584.19 28
PY2022 Recipient $114,214.86 6
PY2022 Principal investigator $488,828.89 25
PY2021 Recipient $9,059.97 3
PY2021 Principal investigator $119,137.29 32
PY2020 Recipient $503.30 1
PY2020 Principal investigator $95,457.26 24
PY2019 Recipient $2,258.03 12
PY2019 Principal investigator $68,758.84 16

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Eli Lilly and Company $9,500.00 12/09/2025 Non-covered Recipient Entity
NORTH STAR MEDICAL RESEARCH LLC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF BRENIPATIDE COMPARED WITH PLACEBO FOR THE TREATMENT OF ADULT PARTICIPANTS WITH ALCOHOL USE DISORDER (RENEW-ALC-2) No dispute reported 06/30/2026 1187886052
Principal investigator 1 Eli Lilly and Company $9,500.00 12/09/2025 Non-covered Recipient Entity
NORTH STAR MEDICAL RESEARCH LLC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF BRENIPATIDE COMPARED WITH PLACEBO FOR THE TREATMENT OF ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE ALCOHOL USE DISORDER (RENEW-ALC-1) No dispute reported 06/30/2026 1187889256
Principal investigator 1 Genentech, Inc. $6,936.00 11/19/2025 Non-covered Recipient Entity
KERLO RESEARCH
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211619750
Principal investigator 1 Genentech, Inc. $3,250.00 10/01/2025 Non-covered Recipient Entity
KERLO RESEARCH
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211619745
Principal investigator 1 Janssen Research & Development, LLC $5,000.00 08/25/2025 Non-covered Recipient Entity
NORTH STAR MEDICAL RESEARCH LLC
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175344248
Principal investigator 1 Genentech, Inc. $1,469.00 07/25/2025 Non-covered Recipient Entity
KERLO RESEARCH
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211619732
Principal investigator 1 Genentech, Inc. $1,750.00 06/13/2025 Non-covered Recipient Entity
KERLO RESEARCH
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211619725
Principal investigator 1 Eli Lilly and Company $1,054.00 04/08/2025 Non-covered Recipient Entity
LIGHTSHIP INC
A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187886384
Principal investigator 1 Eli Lilly and Company $265,880.00 02/11/2025 Non-covered Recipient Entity
NORTH STAR MEDICAL RESEARCH LLC
A STUDY OF REMTERNETUG VERSUS PLACEBO IN EARLY ALZHEIMER'S DISEASE PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE No dispute reported 06/30/2026 1187887672
Principal investigator 1 Eli Lilly and Company $13,628.59 01/27/2025 Non-covered Recipient Entity
LIGHTSHIP INC
A STUDY OF REMTERNETUG VERSUS PLACEBO IN EARLY ALZHEIMER'S DISEASE PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE No dispute reported 06/30/2026 1187884096
Principal investigator 1 Eli Lilly and Company $29,385.00 01/21/2025 Non-covered Recipient Entity
LIGHTSHIP INC
A STUDY OF DONANEMAB VERSUS PLACEBO IN PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE OF ALZHEIMER'S DISEASE No dispute reported 06/30/2026 1187885976
Principal investigator 1 Genentech, Inc. $1,469.00 01/14/2025 Non-covered Recipient Entity
KERLO RESEARCH
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211619714
Principal investigator 1 Genentech, Inc. $5,574.00 01/14/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672154